Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2024-10-04 00:00:00 ET · period of report 2024-10-02 · accession 0001493152-24-039603 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-10-04 | 2024-10-02 | IMDX | James Andrea S. | CFO | P - Purchase | $2.97 | +33.7K | 33.7K | New | +$100.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2024-10-02 | P | A | 33,670 | $2.97 | 33,670 | D | — | — | (F1) Reflects shares of the Issuer's common stock, no par value, purchased by the Reporting Person from the Issuer in a private placement pursuant to that certain Securities Purchase Agreement, dated as of October 2, 2024, by and among the Issuer and the investors signatory thereto. |